Adicet Bio, Inc. Insider Trading Report

RA Capital Management, L.P. and its affiliates, including RA Capital Healthcare Fund LP, Peter Kolchinsky, and Rajeev Shah, reported a series of transactions involving Adicet Bio, Inc. common stock. On February 18, 2026, they acquired 74,577 shares at a weighted average price of $7.04. On February 19, 2026, an additional 74,268 shares were acquired at a weighted average price of $7.21. On February 20, 2026, they purchased 74,751 shares at a weighted average price of $7.27. These transactions were reported on Form 4 filings, with footnotes indicating weighted average pricing and the disclaimer of beneficial ownership except to the extent of pecuniary interest. The reporting persons are significant shareholders, with Peter Kolchinsky and Rajeev Shah acting as managing members of the general partner of the investment manager.